289 related articles for article (PubMed ID: 32507110)
21. Pattern of liver function and clinical profile in COVID-19: A cross-sectional study of 91 patients.
Kumar A; Kumar P; Dungdung A; Kumar Gupta A; Anurag A; Kumar A
Diabetes Metab Syndr; 2020; 14(6):1951-1954. PubMed ID: 33039937
[TBL] [Abstract][Full Text] [Related]
22. Liver impairment in COVID-19 patients: A retrospective analysis of 115 cases from a single centre in Wuhan city, China.
Zhang Y; Zheng L; Liu L; Zhao M; Xiao J; Zhao Q
Liver Int; 2020 Sep; 40(9):2095-2103. PubMed ID: 32239796
[TBL] [Abstract][Full Text] [Related]
23. [Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study].
Liu C; Jiang ZC; Shao CX; Zhang HG; Yue HM; Chen ZH; Ma BY; Liu WY; Huang HH; Yang J; Wang Y; Liu HY; Xu D; Wang JT; Yang JY; Pan HQ; Zou SQ; Li FJ; Lei JQ; Li X; He Q; Gu Y; Qi XL
Zhonghua Gan Zang Bing Za Zhi; 2020 Feb; 28(2):107-111. PubMed ID: 32077660
[No Abstract] [Full Text] [Related]
24. High aspartate aminotransferase to alanine aminotransferase ratio on admission as risk factor for poor prognosis in COVID-19 patients.
Qin C; Wei Y; Lyu X; Zhao B; Feng Y; Li T; Cao H; Yang X; Zhou X; Wang W; You L; Wang Y
Sci Rep; 2020 Oct; 10(1):16496. PubMed ID: 33020546
[TBL] [Abstract][Full Text] [Related]
25. Severe COVID-19 patients with liver injury: a seven-case series.
Li X; Zhang ZC; Zhang PL
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7855-7860. PubMed ID: 32744713
[TBL] [Abstract][Full Text] [Related]
26. [Clinical characteristics of liver damage in 30 patients with severe coronavirus disease 2019 in Sichuan area].
Li T; Deng C; Du Q; Yue R; Lu S; Chen H; Guo Y; Huang X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Aug; 32(8):928-932. PubMed ID: 32912404
[TBL] [Abstract][Full Text] [Related]
27. Kinetic patterns of liver enzyme elevation with COVID-19 in the USA.
Da BL; Mitchell RA; Lee BT; Perumalswami P; Im GY; Agarwal R; Schiano TD; Dieterich D; Saberi B
Eur J Gastroenterol Hepatol; 2020 Nov; 32(11):1466-1469. PubMed ID: 32501877
[TBL] [Abstract][Full Text] [Related]
28. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Yip TC; Lui GC; Wong VW; Chow VC; Ho TH; Li TC; Tse YK; Hui DS; Chan HL; Wong GL
Gut; 2021 Apr; 70(4):733-742. PubMed ID: 32641471
[TBL] [Abstract][Full Text] [Related]
29. Prevalence of liver injury and correlation with clinical outcomes in patients with COVID-19: systematic review with meta-analysis.
Del Zompo F; De Siena M; Ianiro G; Gasbarrini A; Pompili M; Ponziani FR
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):13072-13088. PubMed ID: 33378061
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India.
Gupta N; Ish P; Kumar R; Dev N; Yadav SR; Malhotra N; Agrawal S; Gaind R; Sachdeva H; Covid Working Group OMOTSH
Monaldi Arch Chest Dis; 2020 Nov; 90(4):. PubMed ID: 33169598
[TBL] [Abstract][Full Text] [Related]
31. Routine blood tests as a potential diagnostic tool for COVID-19.
Ferrari D; Motta A; Strollo M; Banfi G; Locatelli M
Clin Chem Lab Med; 2020 Jun; 58(7):1095-1099. PubMed ID: 32301746
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of hepatic enzymes activities in COVID-19 patients.
Hwaiz R; Merza M; Hamad B; HamaSalih S; Mohammed M; Hama H
Int Immunopharmacol; 2021 Aug; 97():107701. PubMed ID: 33930704
[TBL] [Abstract][Full Text] [Related]
33. Clinical and Immune Features of Hospitalized Pediatric Patients With Coronavirus Disease 2019 (COVID-19) in Wuhan, China.
Wu H; Zhu H; Yuan C; Yao C; Luo W; Shen X; Wang J; Shao J; Xiang Y
JAMA Netw Open; 2020 Jun; 3(6):e2010895. PubMed ID: 32492165
[TBL] [Abstract][Full Text] [Related]
34. Liver injury in COVID-19: What do we know now?
Yang HY; Jin B; Mao YL
Hepatobiliary Pancreat Dis Int; 2020 Oct; 19(5):407-408. PubMed ID: 32753332
[No Abstract] [Full Text] [Related]
35. Liver damage at admission is an independent prognostic factor for COVID-19.
Chen LY; Chu HK; Bai T; Tu SJ; Wei Y; Li ZL; Hu LL; Zhu R; Zhang L; Han CQ; Xiao L; He Q; Song J; Liu WH; Zhu QJ; Chen H; Yang L; Hou XH
J Dig Dis; 2020 Sep; 21(9):512-518. PubMed ID: 32713118
[TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 and hepatitis.
Trevenzoli M; Guarnaccia A; Alberici I; Fassan M; Di Meco E; Farinati F; Cattelan AM
J Gastrointestin Liver Dis; 2020 Sep; 29(3):473-475. PubMed ID: 32919428
[No Abstract] [Full Text] [Related]
37. The liver in COVID-19: prevalence, patterns, predictors, and impact on outcomes of liver test abnormalities.
Goel H; Harmouch F; Garg K; Saraiya P; Daly T; Kumar A; Hippen JT
Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e274-e281. PubMed ID: 33369962
[TBL] [Abstract][Full Text] [Related]
38. COVID-19: Abnormal liver function tests.
Cai Q; Huang D; Yu H; Zhu Z; Xia Z; Su Y; Li Z; Zhou G; Gou J; Qu J; Sun Y; Liu Y; He Q; Chen J; Liu L; Xu L
J Hepatol; 2020 Sep; 73(3):566-574. PubMed ID: 32298767
[TBL] [Abstract][Full Text] [Related]
39. Liver injury with COVID-19 based on gastrointestinal symptoms and pneumonia severity.
Kaneko S; Kurosaki M; Nagata K; Taki R; Ueda K; Hanada S; Takayama K; Suzaki S; Harada N; Sugiyama T; Nagasawa M; Izumi N
PLoS One; 2020; 15(11):e0241663. PubMed ID: 33147270
[TBL] [Abstract][Full Text] [Related]
40. Risk factors of severe cases with COVID-19: a meta-analysis.
Ou M; Zhu J; Ji P; Li H; Zhong Z; Li B; Pang J; Zhang J; Zheng X
Epidemiol Infect; 2020 Aug; 148():e175. PubMed ID: 32782035
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
